Ustekinumab demonstrates activity in glucocorticoid-refractory acute GVHD

Bone Marrow Transplant. 2012 May;47(5):747-8. doi: 10.1038/bmt.2011.172. Epub 2011 Aug 29.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial, Phase II
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Drug Resistance
  • Female
  • Glucocorticoids / therapeutic use
  • Graft vs Host Disease / drug therapy*
  • Humans
  • Proteins / therapeutic use*
  • Ustekinumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • Proteins
  • immunosuppressive 40 kDa protein, rat
  • Ustekinumab

Associated data

  • ClinicalTrials.gov/NCT00720629